# A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India

> **NCT05628090** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 47885 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05628090
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-30
- **Primary completion:** 2023-12-29
- **Final completion:** 2023-12-29
- **Target enrollment:** 47885 (ACTUAL)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05628090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05628090, "A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05628090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*